Maravai LifeSciences
MRVI
MRVI
184 hedge funds and large institutions have $766M invested in Maravai LifeSciences in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 66 increasing their positions, 63 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
15% less funds holding
Funds holding: 217 → 184 (-33)
36% less capital invested
Capital invested by funds: $1.2B → $766M (-$431M)
54% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 57
Holders
184
Holding in Top 10
2
Calls
$2.11M
Puts
$252K
Top Buyers
| 1 | +$17.2M | |
| 2 | +$15.1M | |
| 3 | +$9.36M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$5.79M |
| 5 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$4.55M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$13.2M | |
| 3 | -$13.2M | |
| 4 |
ClearBridge Investments
New York
|
-$8.69M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.53M |